Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

March 31, 2009

Conditions
Lung CancerSoft Tissue SarcomaColorectal CarcinomaBreast CancerProstate Cancer
Interventions
DRUG

Lonafarnib

DRUG

Docetaxel

Trial Locations (1)

30308

Emory University Winship Cancer Institute, Atlanta

All Listed Sponsors
collaborator

Aventis Pharmaceuticals

INDUSTRY

collaborator

Schering-Plough

INDUSTRY

lead

Emory University

OTHER